{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T11:14:31Z","timestamp":1675682071837},"reference-count":25,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2021]]},"DOI":"10.3164\/jcbn.21-5","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T22:07:45Z","timestamp":1620338865000},"page":"286-293","source":"Crossref","is-referenced-by-count":1,"title":["A survey on consciousness towards the proper use of metformin and medical cost in Japanese patients with type 2 diabetes"],"prefix":"10.3164","volume":"69","author":[{"given":"Yoshitaka","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisami","family":"Yasuzawa","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Sanwa Kagaku Kenkyusho Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Ishida","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Sanwa Kagaku Kenkyusho Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Sanwa Kagaku Kenkyusho Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577\u20131589.","DOI":"10.1056\/NEJMoa0806470"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854\u2013865.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 American Diabetes Association. 5. Lifestyle management: Standards of medical care in diabetes-2019. Diabetes Care 2019; 42 (Suppl 1): S46\u2013S60.","DOI":"10.2337\/dc19-S005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Garc\u00eda-P\u00e9rez LE, Alvarez M, Dilla T, Gil-Guill\u00e9n V, Orozco-Beltr\u00e1n D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013; 4: 175\u2013194.","DOI":"10.1007\/s13300-013-0034-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Davies MJ, D'Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2018; 61: 2461\u20132498.","DOI":"10.1007\/s00125-018-4729-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Urakami T, Kuwabara R, Yoshida K. Economic impact of diabetes in Japan. Curr Diab Rep 2019; 19: 2.","DOI":"10.1007\/s11892-019-1124-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kameda T, Kumamaru H, Nishimura S, Kohsaka S, Miyata H. Use of oral antidiabetic drugs in Japanese working-age patients with type 2 diabetes mellitus: dosing pattern for metformin initiators. Curr Med Res Opin 2020; 36: 749\u2013756.","DOI":"10.1080\/03007995.2020.1729710"},{"key":"8","unstructured":"8 Ministry of Health, Labour and Welfare. Review of Contraindications of Metformin including \u201crenal impairment\u201d. Pharmaceuticals and Medical Devices Safety Information 2019; 365: 5\u20138."},{"key":"9","unstructured":"9 Recommendations for proper use of metformin. The Japan Diabetes Society. http:\/\/www.jds.or.jp\/modules\/important\/index.php?content_id=20. Accessed 4 Jan 2021. (in Japanese)"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 MacCallum L, Senior PA. Safe use of metformin in adults with type 2 diabetes and chronic kidney disease: Lower dosages and sick-day education are essential. Can J Diabetes 2019; 43: 76\u201380.","DOI":"10.1016\/j.jcjd.2018.04.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Khunti K, Davies MJ. Clinical inertia\u2014Time to reappraise the terminology? Prim Care Diabetes 2017; 11: 105\u2013106.","DOI":"10.1016\/j.pcd.2017.01.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Okemah J, Peng J, Qui\u00f1ones M. Addressing clinical inertia in type 2 diabetes mellitus: a review. Adv Ther 2018; 35: 1735\u20131745.","DOI":"10.1007\/s12325-018-0819-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Leichter SB, Thomas S. Combination medications in diabetes care: an opportunity that merits more attention. Clin Diabetes 2003; 21: 175\u2013178.","DOI":"10.2337\/diaclin.21.4.175"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pan F, Chernew ME, Fendrick AM. Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med 2008; 23: 611\u2013614.","DOI":"10.1007\/s11606-008-0544-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Baumgartner A, Drame K, Geutjens S, Airaksinen M. Does the polypill improve patient adherence compared to its individual formulations? A systematic review. Pharmaceutics 2020; 12: 190.","DOI":"10.3390\/pharmaceutics12020190"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Vaidya V, Anupindi VR, Pinto S, Kaun M. Cost utility analysis of fixed-dose and free-dose combinations of oral medications in type 2 diabetes patients. J Pharm Heal Serv Res 2016; 7: 181\u2013187.","DOI":"10.1111\/jphs.12139"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hanatani T, Sai K, Tohkin M, Segawa K, Saito Y. Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients. Int J Clin Pharm 2015; 37: 537\u2013545.","DOI":"10.1007\/s11096-015-0097-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Reach G, Pechtner V, Gentilella R, Corcos A, Ceriello A. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab 2017; 43: 501\u2013511.","DOI":"10.1016\/j.diabet.2017.06.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Barbosa CD, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence 2012; 6: 39\u201348.","DOI":"10.2147\/PPA.S24752"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 2010; 87: 204\u2013210.","DOI":"10.1016\/j.diabres.2009.11.023"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Zhang W, Tang Y, Huang J, Yang Y, Yang Q, Hu H. Efficacy of inulin supplementation in improving insulin control, HbA1c and HOMA-IR in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. J Clin Biochem Nutr 2020; 66: 176\u2013183.","DOI":"10.3164\/jcbn.19-103"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kubo T, Okuyama K, Zhao X, et al. Factors associated with reluctance to initiate or continue oral antihyperglycemic agent (OAHA) treatments in type 2 diabetes mellitus patients in Japan: an observational patient-reported study. Diabetes Metab Syndr Clin Res Rev 2019; 13: 1201\u20131207.","DOI":"10.1016\/j.dsx.2019.01.034"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. Comparison of medication adherence and persistence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 2018; 20: 1040\u20131043.","DOI":"10.1111\/dom.13160"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Hua L, Lei M, Xue S, Li X, Li S, Xie Q. Effect of fish oil supplementation combined with high-intensity interval training in newly diagnosed non-obese type 2 diabetes: a randomized controlled trial. J Clin Biochem Nutr 2020; 66: 146\u2013151.","DOI":"10.3164\/jcbn.19-64"},{"key":"25","unstructured":"25 Tanaka M, Ito H, Nemoto A, et al. Relationship between the history of intermittent treatment for type 2 diabetes mellitus and the risk of diabetic vascular complications. J Japan Diab Soc 2015; 58: 100\u2013108. (in Japanese)"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/69\/3\/69_21-5\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T04:00:12Z","timestamp":1636171212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/69\/3\/69_21-5\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.21-5","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"21-5"}}